Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transamination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116730849A reveals a high-yield enzymatic route for HIV inhibitor intermediates. Achieve superior purity and scalable supply chain reliability.
Patent CN102675135A details a mild, high-yield method for synthesizing alpha-amino acid esters using triethylamine catalysis, offering significant cost and purity advantages for pharmaceutical manufacturing.
Breakthrough chiral biaryl pyridoxamine catalyst enables high-yield asymmetric transamination with mild conditions, offering reliable supply chain for pharmaceutical intermediates.
Solve PF-07321332 synthesis challenges: 76%+ yield, 98% purity, mild conditions. Eliminate -78°C steps & column chromatography. Scale to 100MT/yr.